Clinical Trials Browser

NIH × Imatinib Mesylate × Breast × Clear all

NCT00087152 2014-06-09

S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer

Phase 2 Completed

27 enrolled 9 charts

Breast Neoplasms

NCT00045188 2013-01-23

Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male